Patent · US Active

Compositions and methods related to diagnosis of prostate cancer

US11761962B2 · kind B2 · utility

1Cited by
40References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2015
Grant dateSep 19, 2023
Priority date
Expiry dateDec 6, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Aspects of the disclosure relate to improved methods for predicting whether a prostate tissue biopsy obtained from a subject will contain detectable prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.